Silkim Pharma

About

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Silkim Pharma's primary focus?

Silkim Pharma focuses on developing novel, protected drug platforms for treating multiple indications, particularly those involving inflammatory pathologies.

When was Silkim Pharma founded?

Silkim Pharma was founded in March 2013.

Where is Silkim Pharma headquartered?

Silkim Pharma is headquartered in Ra'anana, Israel.

What is the employee count of Silkim Pharma?

Silkim Pharma has an employee count in the 1-10 range, with an exact count of 1 employee.

Has Silkim Pharma received any FDA responses for its drugs?

In May 2020, Silkim Pharma's new drug against coronavirus received a response from the FDA in a record time, according to jlm-biocity.org.

Who are the founders of Silkim Pharma?

The founders of Silkim Pharma are Dror Chevion and Prof. Mordechai (Mottie) Chevion.

What is one of Silkim Pharma's key products?

One of Silkim Pharma's key products is Coronzot.

What are the main modes of action for Silkim Pharma's drug platform?

Silkim Pharma's drug platform agents act as potent anti-inflammatory agents, strong iron-chelating agents, and antibiotic agents.

Sectors & technology

Highlights

Tags